The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV
Frontiers in Cardiovascular Medicine · 21.08.2026 · 13
DOI: 10.3389/fcvm.2026.1899273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 21.08.2026. Verfasst von Carmen Ramos Alejos-Pita und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Central Defense Hospital Gómez Ulla, Madrid, Spain. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
Human immunodeficiency virus (HIV) infection has become a chronic condition due to antiretroviral therapy (ART), which has increased life expectancy but is also associated with a higher burden of cardiovascular disease (CVD) in people living with HIV (PLHIV). Lipoprotein(a) [Lp(a)] is an independent cardiovascular risk biomarker; however, its role in PLHIV remains unclear. This study evaluated the relationship between Lp(a) and cardiovascular risk and explored its association with subclinical coronary artery disease.
Methods
Cross-sectional study included PLHIV aged ≥40 years on stable ART with sustained viral suppression. Individuals with prior cardiovascular events or type 1 diabetes or long-standing type 2 diabetes (≥10 years) were excluded. Lp(a) levels and clinical data were collected. Cardiovascular risk was estimated using validated clinical scores; participants with ≥10% risk underwent coronary computed tomography angiography (CTA) to assess coronary anatomy.
Results
A total of 69 patients were included (81% male; mean age 54 years). The median Lp(a) level was 23.4 nmol/L (IQR: 8.2–81.6; mean: 66.7 nmol/L); 29% had ≥75 nmol/L and 23% ≥ 105 nmol/L. A non-significant inverse association was observed between Lp(a) levels and ART duration ( r = −0.209; p = 0.08). Of 46 participants with a Framingham score ≥10%, 23 underwent coronary CTA. Among those with elevated Lp(a), a higher proportion had vulnerable plaques on CTA, although this was not statistically significant; because only 5 participants with elevated Lp(a) underwent CTA, this finding should be regarded as hypothesis-generating.
Conclusions
In this cohort of virologically suppressed PLHIV, a non-significant inverse trend ( p = 0.08) was observed between ART duration and Lp(a) levels. In the subgroup of moderate-to-high cardiovascular risk, the prevalence of coronary plaque vulnerability features was higher among those with elevated Lp(a), although the small number of imaging studies means this observation should be considered hypothesis-generating rather than indicative of an established biological association.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Central Defense Hospital Gómez Ulla, Madrid, Spain.
- University of Alcalá, Madrid, Spain.
- CBRN and Department of Infectious Diseases, Central Defense Hospital Gómez Ulla, Madrid, Spain.
- General Biochemistry Section, Department of Clinical Analysis, Central Defense Hospital Gómez Ulla, Madrid, Spain.
- Research Section, Department of Education, Central Defense Hospital Gómez Ulla, Madrid, Spain.
- Department of Radiology, Central Defense Hospital Gómez Ulla, Madrid, Spain.
Zitieren
APA
Ramos Alejos-Pita, C., Rodríguez Torres, D. J., Mata Forte, T., Tendero de la Asunción, B., Gómez Sanz, J. E., Reyes Luján, J. J., Romano, M., López Soberón, E., Membrillo de Novales, F. J., & Estébanez Muñoz, M. (2026). The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1899273
Vancouver
Ramos Alejos-Pita C, Rodríguez Torres DJ, Mata Forte T, Tendero de la Asunción B, Gómez Sanz JE, Reyes Luján JJ, et al. The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1899273
BibTeX
@article{RamosAlejosPita2026,
author = {Ramos Alejos-Pita, Carmen and Rodríguez Torres, Diego José and Mata Forte, Tatiana and Tendero de la Asunción, Beatriz and Gómez Sanz, Joaquín Enrique and Reyes Luján, Juan José and Romano, Matteo and López Soberón, Edurne and Membrillo de Novales, Francisco Javier and Estébanez Muñoz, Miriam},
title = {The impact of lipoprotein(a) determination in cardiovascular risk stratification among people living with HIV},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1899273}
}
EUVIMED